0
Patients with early stage disease (IA or IIA) are effectively treated with radiation therapy or chemotherapy. The choice of treatment depends on the age, sex, bulk and the histological subtype of the disease. Patients with later disease (III, IVA, or IVB) are treated with combination chemotherapy alone. Patients of any stage with a large mass in the chest are usually treated with combined chemotherapy and radiation therapy. (Wikipedia) For the source and more detailed information concerning your request, click on the related links section (Answers.com) indicated at the bottom of this answer box.
What else can I help you with?
What is the treatment for relapsed-refractory Hodgkin's lymphoma?
Chemo therapy
What has the author Gilbert Bernard Zulian written?
Gilbert Bernard Zulian has written: 'Hodgkin's lymphoma' -- subject(s): Treatment, Hodgkin's disease, Lymphomas
What risk is associated with radiation and chemotherapy treatment for Hodgkin's disease?
The development of a second type of cancer is the most serious risk from radiation and chemotherapy treatment for Hodgkin's disease. In particular, there is a risk of developing leukemia, breast cancer, bone cancer
What were some of Dorothy Hodgkin's best discoveries?
she had a baby
What is the prognosis for Hodgkin's disease?
Hodgkin's Disease is a type of cancer, however it's considered one of the most curable types of cancer known. Patients with advanced levels of Hodgkin's Disease have a 90% survive rate, though survivors are likely to experience complications due to the treatment used.
What is an example of allopathic treatment for Hodgkin's disease?
An example of allopathic treatment for Hodgkin's disease is chemotherapy, which involves the use of drugs to kill cancer cells. This treatment may be used alone or in combination with other therapies such as radiation therapy or stem cell transplantation.
What is the difference between Hodgkins and non Hodgkins disease?
Hodgkin's lymphoma is characterized by the presence of Reed-Sternberg cells, a specific type of abnormal cell, whereas non-Hodgkin lymphoma encompasses a diverse group of blood cancers that do not contain these cells. Hodgkin's lymphoma typically has a more predictable pattern of spread and is often associated with a better prognosis. In contrast, non-Hodgkin lymphoma can vary widely in aggressiveness and response to treatment. The two types also differ in their epidemiology, symptoms, and treatment approaches.
Did Thomas Hodgkin have Hodgkin's disease?
Hodgkin did not have Hodgkin's disease. He discovered it and described the disease in a paper written in 1832. He was an expert in pathological anatomy.
What is the birth name of Howard Hodgkin?
Howard Hodgkin's birth name is Gordon Howard Eliot Hodgkin.
What is non-hodgkin lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
What is Hodgkin Lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
What's Hodgkin Lymphoma?
Non-Hodgkin lymphomas (NHL) are a diverse group of cancers which arise from lymphocytes, a type of white blood cell. NHL is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The broad category of non-Hodgkin lymphoma encompasses diseases with varying courses, treatments, and prognoses.Non-Hodgkin lymphoma is medically classified as a hematological malignancy, meaning that it is a cancer which arises from the blood. Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system, such as the spleen, lymph nodes, or tonsils. The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness. These categories are indolent (or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy. Some forms of non-Hodgkin lymphoma can be cured with chemotherapy, radiation, or hematopoietic stem cell transplantation.There were 55,216 cases of non-Hodgkin lymphoma diagnosed in the United States in 2005 (the most recent year for which statistics area available), and in that year, 20,873 people died from non-Hodgkin lymphoma.
